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Abstract
The current study examined pathways from childhood maltreatment to opioid misuse in
pregnancy. We sampled 93 pregnant women at a high-risk pregnancy clinic at a university
medical center who were in their second trimester or beyond. 55 women were considered
high-risk due to opioid misuse and 38 women were considered high-risk due to medical
reasons other than drug use. Results revealed sexual abuse was significantly associated with
opioid misuse in pregnancy, while physical abuse, emotional abuse, and neglect were not.
Furthermore, women with histories of childhood sexual abuse reported significantly higher
levels of perceived stress during pregnancy than women who did not report a history of
sexual abuse. However, perceived stress did not moderate the relationship between sexual
abuse and opioid misuse. Results suggest adequately screening pregnant women for
childhood sexual abuse history as a part of their prenatal care may help alert medical
providers as to which women could be at an elevated risk for opioid misuse based on their
history of sexual abuse. Integrating trauma-informed care into normal gynecology practice
will encourage women with histories of sexual abuse to seek out medical attention rather than
to avoid it during their pregnancy.
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CHAPTER I
Introduction
The Opioid Misuse Epidemic
Opioid misuse is a growing epidemic in the Unites States (Gottlieb & Woodcock,
2017), with almost 30,000 people dying from opioid overdose in 2014 alone (Rudd, Aleshire,
Zibbell, & Matthew Gladden, 2016) compared to approximately 17,000 opioid-related deaths
in 2010 (Statistics, 2014). Moreover, approximately 25 million people engaged in opioid use
for nonmedical reasons between 2002 and 2011, which ultimately led to almost every state in
the country writing legislation to combat this crisis (Dart et al., 2015). Furthermore, in a
single year (2014-2015), deaths from opioid overdoses rose from 9.0 per 100,000 to 10.4 per
100,000, which is indicative of an 11.4% increase nationwide (Rudd, 2016). Indeed, drug-use
disorders accounted for the largest increase in deaths between 1990 and 2010 (Murray et al.,
2013) and opioid use disorder specifically, accounted for 61% of the deaths within this
category in 2014 (Rudd, 2016), with more people dying from overdosing on opioids than
dying from car accidents (Paulozzi, 2012). In response to these troubling statistics, United
States Congress passed the Drug Addiction Treatment Act (DATA, 2000) to allow physicians
who meet particular qualifications to treat opioid use disorders with narcotic medications in
general medical settings, such as buprenorphine (Zedler et al., 2016). Opioid agonist
medication-assisted treatment (MAT), which is considered to be the most effective approach
to treating opioid use disorder by the World Health Organization (WHO, 2009), was
historically only available through federally regulated opioid treatment programs.
Opioid Misuse and Pregnancy
One setting which physicians have begun treating opioid use disorders with narcotic
medications is in pregnancy clinics. Indeed, the number of women misusing opioids while
pregnant has more than quadrupled between 1999 and 2014, increasing from 1.5 per 1,000
delivery hospitalizations to 6.5 per 1,000 delivery hospitalizations, which translates to a

2
333% increase (Haight, Ko, Tong, Bohm, & Callaghan, 2018). Moreover, in all 28 states
which provided data for this study, rates of opioid misuse in pregnancy were increasing in
this time period. In the state of Tennessee specifically, where the current study was
conducted, opioid misuse in pregnancy increased from 1.19 to 5.77 per 1000 hospital births
between 2000 and 2009 (Patrick et al., 2015), and to 11.6 per 1000 hospital births by 2013
(Warren, Miller, Traylor, Bauer, & Patrick, 2015).
Opioid misuse can have devastating consequences not just for the user, but for their
offspring as well. The dramatic rise in opioid misuse nationally in pregnant women has led
to a 383% increase in Neonatal Opioid Withdrawal Syndrome (NOWS) in offspring between
2000-2012 (Ko, 2016). Between 45-94% of infants exposed to opioids during pregnancy will
go on to develop NOWS (Minozzi, Amato, Bellisario, Ferri, & Davoli, 2013), which is a
postnatal syndrome associated with autonomic overactivity (e.g. sensory issues), central
nervous system irritability (e.g. tremors), and gastrointestinal tract dysfunction (e.g. feeding
difficulties; Hudak & Tan, 2012). Infants born with NOWS are more likely to have birth
complications including low birthweight, toxemia (Minozzi et al., 2013), respiratory
complications (Hudak & Tan, 2012), and decreased head circumference (Towers et al.,
2019). Moreover, offspring of women who misuse opioids while pregnant have a 74 fold
increase in sudden infant death syndrome (Fajemirokun-Odudeyi et al., 2006; Ludlow, Evans,
& Hulse, 2004). Given the serious and sometimes fatal consequences of opioid misuse in
pregnancy (Kaltenbach, Berghella, & Finnegan, 1998), it is imperative to seek a deeper
understanding of what factors contribute to the risk of opioid misuse in pregnancy so that
preventative interventions can target at-risk women before they begin using opioids.
Psychosocial Risk Factors for Opioid Misuse in Pregnancy
Only one study to date has examined psychosocial factors that precipitate pregnant
women beginning to misuse opioids (Towers at al., 2019) . The current study sought to
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expand upon Towers et al. (2019), who conducted psychosocial interviews with 192 pregnant
women with Opioid Use Disorder (OUD) to ask women what factors they believed
precipitated their OUD. They found that the majority of pregnant women misusing opioids
(72%) reported a history of abuse, that was most often sexual abuse (53%), for half of whom
began before age 13. Physical violence was reported by 18%, while verbal abuse was
reported by 4%. Mental illness (e.g. depression, anxiety, or PTSD) was reported by 69-71%
of women and family or peer opioid misuse was reported by 78%. Chronic pain, which is
often assumed to be the precipitating event to opioid misuse, was only reported by 10%. The
current study seeks to expand upon these findings of Towers et al. (2019) by examining selfreported history of child maltreatment in pregnant women who misuse opioids and
comparing maltreatment severity (physical abuse, emotional abuse, neglect, and sexual
abuse) of women who have a high-risk pregnancy due to medical factors and not including
drug misuse. Given Towers et al. (2019) found that sexual abuse was the most often cited
adverse childhood experience for pregnant women prior to begin misusing opioids, we aimed
to examine sexual abuse, in particular, more closely, to investigate whether perceived stress
acts as a moderator in the relationship between sexual abuse and opioid misuse.
Theoretical Background
The self-medication hypothesis argues that an addict’s choice of substance is not
arbitrary. Rather, an individual finds a drug which meets their own psychological need to
alleviate emotional distress (Khantzian, 1987). Thus, the hypothesis suggests that drug use
disorders stem originally from an inability to regulate negative emotions in times of stress
(Khantzian, 2015). Experiencing any subtype of child maltreatment is theorized to inhibit the
development of adequate self-regulation capacities to manage stress, which subsequently
weaves through an individuals’ pattern of experiencing emotions (Khantzian, 2015).
Moreover, it has been theorized that drug users fail to successfully internalize parenting or
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soothing functions, which subsequently inhibits their ability to regulate their emotions later in
life (Wieder & Kaplan, 1969).
Although any woman who has been maltreated (e.g. physical abuse, emotional abuse,
and neglect) as a child may be at risk for misusing opioids to self-soothe during times of
stress, women with sexual abuse histories who are faced with the stress of pregnancy may be
at a particularly increased risk for misusing a drug like opioids, which create a soothing effect
on its’ users. As such, those with sexual abuse histories may utilize less effective coping
strategies like drug use, during a time which reminds them of their abuse (i.e. pregnancy)
than those without sexual abuse histories, in an effort to protect themselves from emotionally
deteriorating in this stressful time (Callahan & Hilsenroth, 2005). From an object relations
perspective, opioids, which decrease physiological arousal, might then provide that soothing
presence needed to adequately cope with stress which the individual cannot find elsewhere
(Wieder & Kaplan, 1969). Women with sexual abuse histories, who are then faced with
stressful life events like pregnancy, which often triggers memories of sexual abuse, might
then subsequently become addicted to the substance that helps them to bear overwhelming
affect associated with these experiences (Khantzian et al., 2005; Khantzian, 1987; Wieder &
Kaplan, 1969). In the current study, we expected that women who report any subtype of
maltreatment (physical abuse, sexual abuse, neglect, emotional abuse) would be more likely
to misuse opioids than those who do not report these maltreatment subtypes, but that sexual
abuse would be most strongly associated with opioid misuse in pregnancy compared to the
other subtypes.
Empirical Literature on Child Maltreatment and Opioid Misuse
Individuals who report child maltreatment histories are more likely than those without
maltreatment histories to engage in misuse of opiates (Heffernan et al. 2000). Heffernan et al.
(2000) found that sexual abuse alone accounted for 8.8% of those reporting maltreatment,
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while sexual abuse or physical abuse accounted for 27% and physical abuse alone accounted
for 24.1%. Opioid users, regardless of gender, were 2.7 times more likely to report a history
of sexual/physical abuse or physical abuse alone. While these findings are significant, they
are limited by the inclusion of only two subtypes of maltreatment: physical abuse and sexual
abuse. Mills found that 52% of an opioid-using sample reported histories of sexual abuse
(Mills, Lynskey, Teesson, Ross, & Darke, 2005), though their findings are limited by not
having included a control group. The current study sought to address the limitations of
previous studies by adding a control of non-opioid users and also investigating emotional
abuse and neglect, particularly within a population of pregnant woman. We expected to
replicate these findings, such that opioid-misusing women would report significantly more
child maltreatment in all subtypes than the control group. Though neglect has not yet been
studied in a population of opioid-misusing pregnant women, previous research in general
opioid-misuse groups have found high rates of both emotional and physical neglect (Conroy,
Degenhardt, Mattick, & Nelson, 2009), so we expected to have similar findings in this regard.
In the current study, we therefore expected to find that pregnant women misusing opioids
would report more child maltreatment than pregnant women who are not misusing opioids in
each maltreatment subtype (physical abuse, sexual abuse, neglect, emotional abuse).
Gender Differences for Child Maltreatment History Reported by Opioid Users
While child maltreatment is a risk factor for opioid misuse in both men and women,
research has found gender differences with regard to maltreatment subtype associated with
opioid misuse. Men who misuse opioids report higher rates of physical and emotional abuse,
while women who misuse opioids report higher rates and severity of sexual abuse (Conroy et
al., 2009). Such findings highlight sexual abuse as a particular risk factor for opioid misuse
among women. In that sample, 72% of opioid users were female while only 36% of opioid
users were male (Conroy et al., 2009). Findings from Conroy et al. (2009) are limited by their
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control group, which also had a history of opioid misuse, though they had not sought
treatment for such use. The current study sought to address these limitations by utilizing a
control group which reports no opioid use, past or present.
Indeed, women with histories of sexual abuse are more likely to report psychological
reasons for why they began using drugs than women without sexual abuse histories
(Bartholomew, Courtney, Rowan-Szal, & Simpson, 2005; Bartholomew, Rowan-Szal,
Chatham, Nucatola, & Simpson, 2002). Furthermore, women with trauma histories have a
higher risk for opioid misuse then men with trauma histories (Meier et al., 2014). Given that
approximately 21,000 women between the ages of 15 and 44 misuse opioids while pregnant
each month in the United States alone (Smith & Lipari, 2017), it is particularly important to
understand underlying pathways from sexual abuse to opioid use in this population to reduce
the devastating consequences opioid use can have on developing fetuses. While we expected
to find more physical abuse, sexual abuse, neglect, and emotional abuse in women who are
misusing opioids while pregnant, we expected that sexual abuse would be most strongly
associated with opioid misuse compared to the other subtypes.
Empirical Literature on the Developmental Consequences of Child Maltreatment
McLaughlin, Sheridan, & Lambert (2014) propose different subtypes of maltreatment
(i.e. sexual abuse versus neglect versus physical abuse) may lead to distinct outcomes. For
instance, they theorize that abuse interferes most with emotional and social processing, while
neglect seems to most disrupt cognitive development. Out of all forms of child maltreatment,
sexual abuse has been found to be the most highly associated with low mental well-being in
adulthood (Hughes, Lowey, Quigg, & Bellis, 2016) and the most costly medical care (Walker
et al., 1999). With this in mind, we planned to investigate the unique sequalae of sexual abuse
as it relates to the development of opioid use in pregnant women specifically. Moreover,
given the severity of psychosocial outcomes of sexual abuse has been associated with the
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severity of the abuse (Bagley & Ramsay, 1986), we plan to investigate how severity relates to
opioid use in pregnancy in the current study. Measuring maltreatment in two ways
(presence/absence and severity) allowed us to gain a deeper understanding of the differential
consequences of child maltreatment with regard to opioid misuse in pregnancy and the extent
to which the nature of the abuse or neglect impacts the likelihood of opioid misuse in
pregnancy.
Empirical Literature on the Relationship between Sexual Abuse and Stress
Research consistently suggests that sexual abuse increases one’s sensitivity to stress
later in life (Kendall-Tackett, 2002; King, Mandansky, King, Fletcher, & Brewer, 2001)
through dysregulation of both the hypothalamic-pituitary-adrenal axis and the endogenous
opioid system (Charney, Deutch, Krystal, Southwick, & Davis, 1993; Cohen, Pickar, &
Dubois, 1983; Davis & Siegel, 2000; Kosten & Krystal, 1988; Van der Kolk, McFarlane, &
Weisæth, 2012). Dysregulation of the hypothalamic-pituitary-adrenal axis results in the
production of abnormally high or low cortisol (Altemus, Cloitre, & Dhabhar, 2003; Heim &
Nemeroff, 2002) which subsequently impairs the stress response throughout life (McEwen,
2000; Sanchez, Ladd, & Plotsky, 2001), potentially putting these individuals at a higher risk
for heightened emotional reactions to stress. Indeed, individuals with histories of sexual
abuse experience significantly higher rates of stress-related diseases (Felitti et al., 2019; Stein
& Barrett-Connor, 2000; Walker, Katon, Roy-Byrne, Jemelka, & Russo, 1993).
However, not all women who experience sexual abuse go on to develop difficulties
regulating stress (Draucker, 1995; Folger et al., 2017; Harvey, 1996; Neiman, 1988; Romans,
Martin, Anderson, O’Shea, & Mullen, 1995): 21% to 49% of children who experience sexual
abuse do not develop any symptoms (Kendall-Tackett, Williams, & Finkelhor, 1993;
McLeer, Deblinger, Henry, & Orvaschel, 1992) and 22% of adult survivors of sexual abuse
exhibit no symptoms (Russell & Russell, 1986). It is therefore possible that women with
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histories of sexual abuse, who go on to develop a heightened stress response, may
subsequently experience greater levels of perceived stress in pregnancy when traumatic
memories of their abuse is triggered, and thus be at an increased risk for opioid misuse to
manage that stress. In the current study, we therefore expected to find that perceived stress
will moderate the relationship between sexual abuse and opioid misuse in pregnancy.
Empirical Literature on Sexual Abuse, Perceived Stress, and Pregnancy
Because pregnancy is naturally a stressful life event for most women (Geller, 2004),
particularly for those with sexual abuse histories (Leeners, Richter-Appelt, Imthurn, & Rath,
2006) and for those with high-risk pregnancies (Wang et al., 2019), we sought to investigate
sexual abuse, specifically, more closely. Indeed, women with sexual abuse histories
experience significantly more difficult pregnancies than those without sexual abuse histories,
including increased discomfort and health complaints, higher nonscheduled contact with their
medical provider, and a higher number of ultrasound examinations (Littleton, 2015; Lukasse,
Schei, Vangen, & Øian, 2009). Women with histories of childhood sexual abuse do indeed
report increased levels of stress during pregnancy, with many stages of pregnancy, prenatal
care, and delivery being complicated by memories of sexual abuse (Jacobs, 1992). Indeed,
pregnancy has been theorized to function as a re-traumatization of sexual abuse which
occurred in childhood (Lev-Wiesel, Daphna-Tekoah, & Hallak, 2009). The current study
sought to fill this gap in the literature by examining whether pregnant women with sexual
abuse histories report more perceived stress and examining whether perceived stress may
play a role in the potential relationship between sexual abuse and opioid misuse in pregnancy.
We expected that perceived stress would moderate the relationship between child sexual
abuse and opioid misuse in pregnancy.
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Empirical Literature on the Relationship between Perceived Stress and Opioid Misuse
Past research suggests a relationship between the endogenous opiate system and the
experience of trauma (Cohen et al., 1983). Opioids inhibit the locus coeruleus, which has
been implicated in stress reaction (Kosten & Krystal, 1988). Indeed, researchers have
subsequently theorized that opioid users, in particular, may utilize opioids as a means of selfmedication due to the analgesic properties of opioids which can ease symptoms of
hyperarousal associated with the experience of stress (Bremner et al., 1994; Charney et al.,
1993; Kosten & Krystal, 1998). Indeed, past research proposes that opioids may numb
intense emotional pain, which would normally disorganize an individual with a limited ability
to self-regulate (Blatt, Rounsaville, Eyre, & Wilber, 1984; Khantzian, Mack, & Schatzberg,
1974; Kosten & Krystal, 1988). Previous research has also found gender differences in opioid
use, such that the risk for co-occurring PTSD symptoms and opioid misuse were
approximately 3 times greater for women versus men (Meier et al., 2014). Thus, it is possible
that child maltreatment and perceived stress interact to produce an increased risk for opioid
use in women.
Empirical Literature on Sexual abuse, Pregnancy, and Opioid Use
There has been only one study to date investigating the relationship between sexual
abuse and opioid misuse in pregnancy (Towers et al., 2019). While they found strikingly high
rates of childhood adversity, particularly with regard to sexual abuse, their findings are also
limited by a lack of control group and by an interview method that did not cover all subtypes
and dimensions of maltreatment. In the current study, we sought to build on these findings by
utilizing a larger sample size and implementing a quantitative design, which includes a
control group of women without opioid misuse who also have high-risk pregnancies, and a
valid questionnaire about childhood maltreatment. Given both studies found sexual abuse to
be most prevalent in their samples of opioid-misusing pregnant women, we expected that
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sexual abuse would be most strongly associated with opioid use in pregnancy compared to
the other maltreatment subtypes.
Hypotheses
1. (a) There will be significantly more child maltreatment (presence/absence; sexual
abuse, physical abuse, emotional abuse, neglect) observed in the opioid group than the
non-opioid group and (b) there will be significantly more child maltreatment
(severity; sexual abuse, physical abuse, emotional abuse, neglect) observed in the
opioid group than the non-opioid group.
2. (a) Presence of sexual abuse will be most strongly associated with opioid misuse in
pregnancy compared to the other maltreatment subtypes (presence/absence of
physical abuse, emotional abuse, emotional neglect, physical neglect) and (b) Severity
of sexual abuse, duration of sexual abuse, and age of the onset of sexual abuse will be
associated with opioid misuse in pregnancy, such that women who experienced more
severe, longer-lasting and earlier onset sexual abuse will be more likely to misuse
opioids in pregnancy than women who experienced less severe, shorter duration, or
later age onset of sexual abuse.
3. (a) Women who report histories of sexual abuse (presence/absence) will report higher
levels of perceived stress than women who do not report histories of sexual abuse and
(b) women who report more severe sexual abuse (severity) will report higher levels of
perceived stress than women who report less severe sexual abuse.
4. The effects of sexual abuse (severity) on opioid misuse (presence/absence) will be
moderated by perceived stress, such that women who report experiencing sexual
abuse and high levels of perceived stress will be more likely to misuse opioids in
pregnancy than women who report experiencing sexual abuse but did not experience
high levels of perceived stress.
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Chapter II
Method
Procedures
High-Risk Pregnancy Appointment. Participants were recruited from a High-Risk
Pregnancy Clinic at a University Medical Center in the Southeastern United States, which
sees patients from both urban and rural areas. Any pregnant woman being seen at the clinic
was eligible to participate in the study if they were over the age of 18 years old and were at
least in their second trimester of their pregnancy. Women were asked by the receptionist at
check-in whether they would be interested in participating in a 30-minute study on high-risk
pregnancy. If they expressed interest in participating in the study, they were escorted by a
nurse to a private examination room to meet with a research assistant. At this time, the
research assistant explained the purpose of the study, what would be required of the
participant, answered any questions the participant had, and obtained informed consent,
Consent included willingness to participate in the study, complete questionnaires and to allow
the research assistants access to their medical charts for additional information (i.e. urinalysis
results, demographics etc.). They received a $25 gift certificate to Walmart as compensation
for the time required to take part in the study.
Participants
Ninety-three women participated in the current study. Fifty-five women were highrisk due to opioid misuse disorder and thirty-eight were high risk due to medical factors (not
drug use), such as multiples in pregnancy, morbid obesity (body mass index > 50),
cardiovascular, cardiopulmonary, or rheumatologic diseases. Women were initially referred
to the high-risk pregnancy clinic by their primary care physicians. Women in both groups
were seen at the high-risk pregnancy clinic approximately monthly until 28 weeks gestation,
biweekly until 36 weeks gestation, and weekly from 36 weeks gestation until delivery.
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Demographics. Demographic information was obtained from participants’ medical records.
See Table 1.
Measures
Maltreatment. Child maltreatment subtypes and dimensions were measured with the
Maltreatment and Abuse Chronology of Exposure (MACE; Teicher & Parigger, 2015), which
is 52-item questionnaire that assesses child maltreatment severity along continuous scales
which provide information regarding when and for how long an individual experienced
maltreatment and how severe the maltreatment was. Subscales for each maltreatment subtype
were made up of yes/no questions. The subtypes of maltreatment used in the current study are
sexual abuse, physical abuse, emotional abuse and neglect. Severity of each subtype is
calculated either by the total number of items endorsed, which is recalibrated to a total
severity level between 0-10 (if there were at least five) or were rescored based on linear
interpolation of items endorsed (if there were less than five). The MACE has been validated
using other measures of childhood trauma (Child Trauma Questionnaire, CTQ; Bernstein et
al., 1994), Adverse Childhood Experiences, (ACE; Dube et al., 2003) and accounted for more
variance in psychiatric symptoms than did the ACE or CTQ. The MACE was developed
using item response theory and provides excellent reliability utilizing the Andersen’s
Likelihoood ratio test (Teicher & Parigger, 2015). In the current study, we used
presence/absence of each maltreatment subtype and severity of sexual abuse (7 items),
physical abuse (6 items), emotional abuse (10 items), emotional neglect (5 items) physical
neglect (5 items). In addition to a continuous severity rating, we also plan to assess
presence/absence with a categorical variable. Presence of a maltreatment subtype will be
coded (1) if the participant endorses any of the items pertaining to this subtype, regardless of
severity.
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Opioid Use. Participants were assigned to the opioid group based on medical records
of urine-based assays conducted by their medical provider at their medical appointments.
Specifically, we utilized a dichotomous variable (yes/no) based on the participants’ urine
sample taken within 30 days prior to taking part in the study. Women will be assigned to the
opioid group if either prescribed (e.g., methadone or buprenorphine) or non-prescribed
opioids are detected. Each participant had at least one urine sample within 30 days prior to
participating in the study. For the purposes of the current study, we were specifically
interested in examining opioid use. For this reason, women who tested positive for drugs
other than opioids (e.g. marijuana, alcohol, cocaine, or stimulants) were excluded from our
sample if they were not also misusing opioids. In the current sample, there are 55 participants
in the opioid group and 38 participants in the comparison group.
Perceived Stress. Perceived stress was measured through the stress subscale of the
Depression, Anxiety, and Stress Scale (DASS-21; Lovibond & Lovibond, 1995), which
consists of 21 items derived from the original 42-item DASS long-form. The stress subscale
seeks to measure overall emotional response to stressors. Items seek to examine levels of
irritability, agitation, impatience, and general tension. The DASS asks individuals to indicate
the extent to which they experience these feelings on a 4-point scale, which range from 0,
indicating the statement does not apply to them at all, to 3, indicating the statement applies to
them “very much or most of the time.” The score for the stress subscale is obtained by
totaling all items in the scale and multiplying the total sum by two (to double it), which
matches the scoring for the long form of the DASS-42 (Lovibond & Lovibond, 1995). A
higher score indicates a higher level of perceived stress. The DASS-21 has been
demonstrated to have adequate internal consistency and convergent validity across various
populations (Antony, Bieling, Cox, Enns, & Swinson, 1998; Clara, Cox, & Enns, 2001). In
the current sample, the Cronbach’s alpha for the stress subscale was α = .80.
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Chapter III
Results
Preliminary analyses
Preliminary analyses revealed differences between groups on age and minority ethnic
background, such that women who used opioids during pregnancy were more likely to be
older and less likely to be from an ethnic minority background than those in the comparison
group. Age and ethnic minority background was controlled for in the analyses. See Table 1
for group differences on demographic variables.
To test our hypothesis 1(a), we conducted 5 logistic regressions to determine if
child maltreatment (sexual abuse, physical abuse, emotional abuse, and neglect) would be
associated with more opioid misuse in pregnancy. The categorical variable of child
maltreatment (presence/absence) served as the independent variable and opioid misuse served
as the dependent variable. Age and ethnic minority background were entered in step 1. Child
maltreatment subtype (i.e. sexual abuse, physical abuse, emotional abuse, neglect) was
entered in step 2.
Logistic regression analyses revealed presence of maternal sexual abuse was
significantly associated with opioid misuse in pregnancy (p < .05). However, maternal
physical abuse, emotional abuse, and neglect were not significantly associated with opioid
misuse in pregnancy. See Table 2.
To test our hypothesis 1(b), that the severity of child maltreatment (sexual abuse,
physical abuse, emotional abuse, and neglect) would be associated with more opioid misuse
in pregnancy, we conducted 5 binary logistic regressions. The severity variable of child
maltreatment (severity rating) served as the independent variable and opioid misuse served as
the dependent variable. Age and ethnic minority background were entered in step 1. Child
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maltreatment subtype (i.e. sexual abuse, physical abuse, emotional abuse, neglect) was
entered in step 2.
Logistic regression analyses revealed severity of maternal sexual abuse as marginally
significant in be associated with opioid misuse in pregnancy (p = .06). However, maternal
physical abuse, emotional abuse, and neglect were not significantly associated with opioid
misuse in pregnancy. See Table 3.
To test hypothesis 2(a), that the presence of sexual abuse would be most strongly
associated with opioid misuse in pregnancy compared to the presence of other maltreatment
subtypes (physical abuse, emotional abuse, and neglect), we conducted a binary logistic
regression. Presence/absence of sexual abuse served as the independent variable and opioid
misuse in pregnancy served as the dependent variable. Presence/absence of age, ethnic
minority background, physical abuse, emotional abuse, and neglect were entered in step 1.
Presence/absence of sexual abuse was entered in step 2. Logistic regression analyses revealed
presence of sexual abuse was most strongly associated with opioid misuse compared to the
presence of physical abuse, emotional abuse, and neglect (p < .05). See Table 4.
To test hypothesis 2(b), that severity of sexual abuse would be most strongly
associated with opioid misuse in pregnancy compared to the severity of other maltreatment
subtypes, we conducted a binary logistic regression. Sexual abuse severity served as the
independent variable and opioid misuse in pregnancy served as the dependent variable. Age,
ethnic minority background, and severity of physical abuse, emotional abuse, and neglect
were entered in step 1. Presence/absence of sexual abuse was entered into step 2. Logistic
regression analyses revealed severity of sexual abuse was most strongly associated with
opioid misuse compared to the severity of physical abuse, emotional abuse, and neglect
( p = .07). See Table 5.
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To test hypothesis 3, that women who report histories of sexual abuse
(presence/absence) would report higher levels of perceived stress than women who do not
report histories of sexual abuse, we conducted an ANOVA. Sexual abuse (absence/presence)
served as the independent variable and perceived stress served as the dependent variable. Age
and ethnic minority status were entered as covariates. Analyses revealed maternal sexual
abuse was significantly associated with maternal perceived stress F (1, 93) = 3.29, p < .05.
To test hypothesis 4, that the effects of sexual abuse (presence/absence) on opioid
misuse would be moderated by perceived stress, we conducted a binary logistic regression.
Sexual abuse and stress served as the independent variables. Opioid misuse served as the
dependent variable. For step 1, we entered age, ethnic minority background, sexual abuse and
stress as the covariates. For step 2, we entered the interaction term, which was
presence/absence of sexual abuse X stress. Analyses revealed maternal perceived stress did
not moderate the relationship between sexual abuse and opioid misuse (p = .26). See Table 6.
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Chapter V
Discussion
Summary of Findings
The current study is the first to find that women with histories of childhood sexual
abuse are more likely to misuse opioids than women without such histories. We specifically
found that the presence of sexual abuse was significantly associated with opioid misuse in
pregnancy, while presence of physical abuse, emotional abuse, and neglect was not.
Furthermore, we also found that the severity of sexual abuse was marginally significantly
associated with opioid misuse in pregnancy, while physical abuse, emotional abuse, and
neglect severity were not. Moreover, the presence of sexual abuse was significantly
associated with opioid misuse above and beyond presence of the other maltreatment
subtypes. Additionally, the severity of sexual abuse was marginally significantly associated
with opioid misuse above and beyond severity of other maltreatment subtypes. Lastly,
women who reported sexual abuse histories also reported higher levels of perceived stress
than women who did not report such histories, but perceived stress did not moderate the
relationship between sexual abuse and opioid misuse.
Sexual Abuse and Opioid Misuse
Our finding that sexual abuse was associated with opioid misuse in pregnancy is
consistent with findings from Towers et al. (2019) who found that opioid-misusing pregnant
women reported histories of sexual abuse more often than any other kind of child
maltreatment. Furthermore, our study built upon these findings by adding a high-risk control
group and an empirically-supported measure of maltreatment rather than depending on
interview methodology. However, our findings did not support previous research which
found that opioid users were more likely to report a history of physical abuse than non-opioid
users (Heffernan et al., 2000). In the current sample, only sexual abuse was associated with
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opioid misuse in pregnancy. Physical abuse, emotional abuse, and neglect were not. It is
important to note that Heffernan et al. (2000) examined both men and women in their sample.
Previous research has found gender differences such that men who misuse opioids report
elevated rates of physical and emotional abuse, while women who misuse opioids report
elevated rates of sexual abuse (Conroy et al., 2009). Such gender differences might explain
why our results differ from Heffernan et al. (2000), but are consistent with previous research
specifically on pregnant women.
Sexual Abuse, Perceived Stress, and Opioid Misuse
Contrary to our hypothesis, perceived stress did not moderate the relationship
between sexual abuse and opioid misuse. Our findings suggest that sexual abuse was
associated with opioid misuse but that the likelihood of subsequent opioid misuse following
sexual abuse does not differ based on level of perceived stress reported during pregnancy.
Moreover, experiencing sexual abuse alone, regardless of a woman’s level of perceived
stress, significantly increased the likelihood of opioid misuse. Such findings support the need
to identify patients with sexual abuse history before they become pregnant to avoid the
development of opioid misuse. One way to identify these patients would be through
screening for Adverse Childhood Experiences (ACEs) in medical visits. Identifying patients
with histories of adverse childhood experiences as children that include sexual abuse would
increase access to preventative treatment for these patients before they become mothers
themselves.
Screening for (ACEs) in Pediatrician Visits
One way to do this would be to screen for sexual abuse in Primary Care visits in
childhood. Despite a strong link between adverse childhood experiences and long-lasting
health problems in adulthood (Hughes, Lowey, Quigg, & Bellis, 2016), this is not standard
practice. Indeed, only 4% of pediatricians report asking about all adverse childhood
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experiences and 32% report not asking about any adverse childhood experiences. For those
who do report asking about ACEs, they generally only ask about family history of mental
illness and whether a child’s parents have divorced or separated (Kerker et al., 2016). The
majority of physicians do not ask about sexual abuse, physical abuse, or neglect.
One reason medical providers may not ask about ACEs during their visits is lack of
familiarity with ACEs and their impact on physical health. Kerker et al. (2016) found that
only 2% of pediatricians reported being “very familiar” with the ACEs study and 76% of
pediatrics reported that they were not at all familiar with the study. Furthermore, 79% of
physicians felt that asking about socio-emotional stressors within a family were outside the
scope of their job. This is particularly troubling given the strong bidirectional relationship
with psychological and physical health (Dube et al., 2003). While most pediatricians report
feeling as though inquiring about ACEs is outside their scope of practice, research has found
parents strongly support pediatricians screening for ACEs during their primary care visits
(Conn et al., 2018). With this in mind, it is also possible that pediatricians realize that should
a child answer “yes” to questions regarding ongoing trauma, they would need to contact
Child Protective Services, which could create a rupture in the trusting relationship between
parent and provider. Furthermore, pediatricians may worry their involvement with DCS could
then cause a parent to stop seeking medical care for their child.
Screening for ACEs in Adult Primary Care Visits
While screening for intimate partner violence is much more common place (Women,
Yawn, Yawn, & Uden, 1992), screening for child maltreatment histories among adult
primary care patients is also quite uncommon. Despite 20-50% of adult patients reporting
history of child sexual, physical, or emotional abuse, 25% of adult primary care providers
report they rarely or never screen adult patients for child maltreatment history (Weinreb et
al., 2010). Moreover, adult primary care physicians report similar feelings regarding
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screening for ACEs as do pediatricians; one study found that approximately two-thirds of
adult primary care physicians did not believe that they should routinely screen for childhood
sexual abuse. Less than one third of primary care physicians report screening female patients
for child maltreatment and about one in eight physicians report screening male patients for
child maltreatment. Such beliefs subsequently impact the rate of those who do screen for such
histories (Richardson et al., 2001). Indeed, Richardson et al. (2001) found that only one in
one hundred physicians screened for such a history. Of note, mandatory reporting laws are
quite different for adults reporting pervious histories of trauma. If providers began regularly
inquiring about ACEs among patients, they could begin to make psychotherapy referrals so
these patients, child and adult, could receive adequate treatment. Doing so would likely
improve their physical health as well.
Screening for ACEs in Gynecologist Visits
We know that sexual abuse also predicts health outcomes specific to pregnant women,
such as obstetric problems, challenges with breastfeeding, and adverse outcomes for their
infants (Leeners, Richter-Appelt, Imthurn, & Rath, 2006). Moreover, women with sexual
abuse histories are more likely to avoid certain routine gynecological procedures, even
outside of exams related to pregnancy, such as Pap smears and mammograms (Farley,
Golding, & Minkoff, 2002). Screening pregnant women for childhood sexual abuse history as
a part of their prenatal care may help alert medical providers as to which women could be at
an elevated risk for opioid misuse based on their history of sexual abuse. Furthermore,
screenings may also allow gynecologists to provide emotional support, psychoeducation, and
referrals for psychotherapy, thus decreasing the risk of opioid misuse in pregnancy
(American Academy of Pediatrics, 2014). Moreover, knowledge of sexual abuse history may
also enable gynecologists to practice more trauma-informed care. For instance, providing a
patient a sense of safety and control by requesting permission to touch a patient and allowing
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them to stop the procedure when they feel uncomfortable can minimize the risk of
retraumatizing a patient with such a history (Havig, 2008). Implementing these practices in
medical disciplines beyond gynecology, where patients with sexual abuse histories are likely
to feel the most anxiety, would likely improve the encourage these patients to seek regular
medical care, provide them more pathways to access proper psychotherapy treatment, and
improve provider-patient relationships and related outcomes.
Implications for Patient Care
Gynecologists can then draw associations between current difficulty with medical
care which may bring up memories of past sexual abuse (McKegney, 1993). Doing so may
encourage patients with histories of sexual abuse to seek out medical attention rather than to
avoid it. Indeed, psychological insight regarding behavioral symptoms underlies many of the
major types of empirically-supported psychotherapy (Connolly Gibbons, Crits-Christoph,
Barber, & Schamberger, 2007). Such insight would likely be useful for both the patient and
the physician. Indeed, reflective functioning, the ability to interpret underlying emotional
states, has been found to mediate the relationship between childhood sexual abuse and opioid
misuse severity in pregnancy (Macfie et al., 2020). Havig (2008) notes that trauma survivors
may be labeled as “difficult” by providers when their trauma history interrupts the patientprovider relationship. Such labels, and resulting attitudes from providers, may subsequently
lead to the patient feeling revictimized and stigmatized once again (Roberts, 1996). As a
result, feelings of victimization may then lead the patient to avoid medical care all together or
to resort to substances to numb the psychological pain.
Empirical Literature on Perceived Stress, Income, and Opioid Misuse
Our findings must be conceptualized within the broader context of how opioid
addiction became the devastating epidemic that it is today. Prior to the 1990s, opioid
prescription for pain was not widespread. Relatedly, nor was opioid use for psychological
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pain. Around this time, researchers began to argue that opioids could be utilized more longterm, citing their addictive potential to be quite low (Portenoy & Foley, 1986; Zenz et al.,
1992). The pharmaceutical industry was then able to promote opioid prescription to medical
providers unfamiliar with the addictive potential of such drugs. Indeed, it has been theorized
that in a society exhibiting a marked intolerance of both physical pain, and emotional pain,
the profits of opioid prescription may have outweighed the risk of addiction, and death
(deShazo, Johnson, Eriator, & Rodenmeyer, 2018). As Sir Angus Deaton noted in his
testimony on the economic aspects of the opioid crisis to the United States Congress, “Selling
heroin is profitable and illegal. Selling prescription drugs is profitable and legal” (Deaton,
2017). Providers began to prescribe opioids more and more frequently (Zhou et al., 2016) and
ultimately the American Pain Society and the American Academy of Pain Medicine stated
their support for opioid use as a treatment for chronic pain (Haddox et al., 1997).
Subsequently, we saw a significant increase in opioid use, with approximately 25 million
Americans misusing the drug between 2002 and 2011 (SAMHSA, 2012).
Such an increase disproportionally impacted the Appalachian region of the United
States, where there are significant differences in employment, education, and socio-economic
status compared to the rest of the country. Moreover, recent data suggest the higher mortality
rate found among Appalachia, where the current study was conducted, is in large part due to
“diseases of despair,” such as alcohol abuse, illicit drug use, prescription drug use, and
suicide which correspond with such disparities (Meit, Heffernan, Tanebaum, Hoffmann,
2017).
Socio-Economic Status and Opioid Use
While physicians have begun prescribing opioids less often in general (IQVIA, 2018),
opioids are prescribed more often to patients who come from low socioeconomic
backgrounds than to patients who come from more economically advantaged backgrounds
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(Grol-Prokopczyk, 2019). While a significant portion of opioid use is illicit, increased
prescriptions increase the amount of opioids sold illegally, particularly in economically
disadvantaged communities. Given we know that childhood maltreatment and poverty are
strongly associated (Kim & Drake, 2018) and that poverty is related to stress (Marmot &
Wilkinson, 2005), those who are at the greatest risk for opioid misuse may be the very
patients which medical providers are most likely to prescribe opioids to. While there are
many alternatives to opioid prescription (White, 2017), more socioeconomically
disadvantaged patients may not have adequate health insurance to cover such treatments
(Grol-Prokopczyk, 2019). As such, medical providers may be more likely to prescribe
opioids to low-income populations which could not afford out-of-pocket costs for alternative
treatment methods. In the current sample, all participants received Medicare. Future research
should examine how frequency and severity of opioid misuse during pregnancy differs based
on socio-economic status. Furthermore, it is possible that financial stability is associated with
other protective factors which promote resilience among childhood sexual abuse victims.
With this in mind, it is possible that poverty could partially mediate the relationship between
childhood sexual abuse and opioid misuse in pregnancy.
Strengths and Limitations
This is the first study to utilize a control group of any kind to compare child
maltreatment histories of opioid misusing and non-opioid misusing pregnant women. We
built upon the findings of Towers et al. (2019) by using an empirically validated measure of
maltreatment rather an unstructured interview to gather maltreatment data. Moreover, our use
of both categorical and continuous measures of maltreatment allowed us to consider the
impact of the severity of such maltreatment on opioid misuse in pregnancy. Examining
maltreatment in this way enabled us to further understand whether it is merely the presence of
the maltreatment which puts women at a greater risk of opioid misuse or if the severity of the
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maltreatment is what puts women at a greater risk. Indeed, severity of psychosocial outcomes
of sexual abuse has been associated with the severity of the abuse (Bagley & Ramsay, 1986).
One limitation of the current study was that we did not consider age of onset of
sexual abuse, which has also been associated with severity of psychosocial outcome (Bagley
& Ramsay, 1986; Sedney & Brooks, 1984; Sirles, Smith, & Kusama, 1989). Future research
should aim to examine if the age at which sexual abuse begins relates to the likelihood of
opioid misuse occurring in pregnancy. We also only gathered retrospective data, so it is
possible not all sexual abuse was reported. Indeed, research has found that not all sexual
abuse is remembered (Brown, Schelfin, & Whitfield, 1999). We also did not consider the
severity of the opioid misuse, which could be related to sexual abuse severity as well. Future
research should also consider frequency and quantity of opioid consumption as it relates to
childhood sexual abuse. Furthermore, we did not gather data regarding whether these women
were first time mothers. It is possible that women who had previously had a pregnancy would
exhibit lower, or higher levels of stress as a result.
Moreover, all participants in our sample were considered low socio-economic status.
Although Medicaid coverage is be associated with increased likelihood of misusing opioids,
opioid misuse impacts women from all socio-economic backgrounds (Grol-Prokopcyzk,
2018; Frenk et al., 2015). With this in mind, it will be important for future research to survey
women from higher socio-economic backgrounds as well. In the current study, our sample
was relatively homogeneous with regard to racial identity, with most of our participants
identifying as Caucasian. Future research should aim to survey a diverse group of women to
examine whether our findings generalize to other racial groups. We also unexpectedly found
that age was a strong predictor of opioid misuse, such that women who are older are more
likely to misuse opioids during pregnancy compared to women who are younger. It is
possible that older women in our sample had dealt with such trauma for longer without
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adequate psychotherapeutic intervention and thus were at an increased risk for opioid misuse.
It is also possible that older women in our sample that experienced previous pregnancies
which made the current pregnancy more stressful, thus increasing their risk for selfmedicating with opioids. Future research should examine factors which might increase risk
for opioid misuse based on age.
Implications of the current study are limited due to the cross-sectional design. For
instance, measuring perceived stress before, during and after pregnancy and duration and
severity of opioid misuse during, before, and after pregnancy would allow us to better
understand the timeline of their symptoms. It is possible that women abusing opioids were
more stressed during pregnancy due to the potential harm their drug use might be causing
their baby in utero and not because they were more stressed prior to beginning to use opioids.
Likewise, it is also possible that some women began using opioid before their pregnancy
began and some began using opioids while pregnant. It will be important in future research to
distinguish any differences between these two groups.
Conclusion
Opioid misuse creates unique challenges for pregnant women, their providers, and
their unborn offspring. Women who experienced sexual abuse as children are more likely to
avoid gynecological procedures. Furthermore, despite women reporting they prefer
physicians to ask about trauma history, most physicians feel ill-prepared to inquire about a
patient’s ACEs during medical appointments and many feel it is beyond the scope of their
job. Adequately screening pregnant women for childhood sexual abuse history as a part of
their prenatal care may help alert medical providers as to which women could be at an
elevated risk for opioid misuse based on their history of sexual abuse. Given that sexual
abuse history substantially increases the likelihood of opioid misuse in pregnancy, it is
crucial for medical providers to integrate trauma-informed care into normal gynecology
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practice. Doing so will encourage women with histories of sexual abuse to seek out medical
attention rather than to avoid it during their pregnancy.
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Table 1. Demographics and Gestation Differences between Opioid and High-Risk Medical
Comparison groups
Variables

Variable
Age
Gestation
Minority Ethnic Background
Employed
Has Partner
Medicaid
*p < .05

Overall
Sample
(N=93)

Opioid
(n = 55)

M (SD)
M(SD)
27.2 (4.3) 28.2 (4.4)
26.8 (7.9) 27.6 (7.9)
%
%
16
7
17
15
38
36
100
100

Comparison Opioid vs.
(n = 38) Comparison
M(SD)
25.7 (3.6)
25.7 (7.9)
%
29
21
39
100

t
2.94*
1.08
χ2
7.81*
0.69
0.09
0.00
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Table 2. Presence of Maltreatment and Opioid Misuse
B
Physical abuse
Neglect
Sexual abuse
Emotional abuse
*p < .05

.19
.22

S.E.
.54
.28

Wald
.12
.60

1.16

.53

.10

.28

df
1
1

Sig.
.73
.44

Exp(B)
1.21
1.24

4.75

1

.03*

3.17

.13

1

.72

1.10
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Table 3. Severity of Maltreatment and Opioid Misuse
B
S.E.
Physical abuse
.03
.07
Emotional abuse
.03
.04
Sexual abuse
.19
.10
Neglect
.04
.06
*p < .05

Wald
.12
.61
3.42
.38

df
1
1
1
1

Sig.
.73
.44
.06
.38

Exp(B)
1.03
1.21
1.21
1.04
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Table 4. Presence of Sexual Abuse versus Other Maltreatment Subtypes
B
S.E.
Wald
Minority status
-1.27
.67
3.5
Age
.14
.06
5.10
Physical abuse
.08
.61
.02
Neglect
.07
.38
.04
Emotional abuse
-.23
.39
.33
Sexual abuse
1.25
.59
4.44
Constant
-3.37
1.69
3.99
*p < .05

df
1
1
1
1
1
1
1

Sig.
Exp(B)
.06
.28
.02*
1.15
.90
1.09
.85
1.08
.56
.80
.04*
3.50
.05*
.03
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Table 5. Severity of Sexual Abuse versus Other Maltreatment Subtypes
B
S.E.
Wald
Minority status
-1.25
.67
3.49
Age
.13
.06
5.06
Physical abuse
-.09
.12
.61
Neglect
.02
.07
.10
Emotional abuse
-.02
.08
.07
Sexual abuse
.24
.13
3.31
Constant
-3.16
1.62
3.80
*p < .05

df
1
1
1
1
1
1
1

Sig.
.06
.02*
.43
.74
.79
.07
.05

Exp(B)
.29
1.15
.91
1.02
.98
1.27
.04
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Table 6. Sexual Abuse, Perceived Stress, and Opioid Misuse
B
S.E.
Wald
Minority status
-1.18
.71
2.76
Age
.16
.07
6.45
Perceived stress
.05
.03
2.85
Sexual abuse
-.50
1.33
.14
Perceived stress X sexual abuse
.08
.07
1.26
Constant
-4.95
1.87
6.99
*p < .05

df
1
1
1
1
1
1

Sig.
Exp(B)
.10
.309
.01*
1.178
.09
1.049
.71
.605
.26
1.085
.01*
.007
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